The “major questions doctrine” addresses the issue of how far federal agencies such as the Food and Drug Administration (FDA) can make policy on their own initiative, and how far they need explicit statutory authorisation. This report will analyse if any of the upcoming tobacco-related regulations may be challenged under this doctrine, including the menthol ban and the policy relating to nicotine levels.
“ Will the ‘major questions doctrine’ be used in tobacco regulation in the US? ”
Buy report request information:
“ Will the ‘major questions doctrine’ be used in tobacco regulation in the US? ”
We also invite you to enjoy our FREE TRIAL
Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.